{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:49:17Z","timestamp":1790790557374,"version":"4.1.0"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Dutch Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Psychology Review"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.cpr.2025.102581","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T20:19:24Z","timestamp":1743452364000},"page":"102581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["The differential effects of medicinal cannabis on mental health: A systematic review"],"prefix":"10.1016","volume":"118","author":[{"given":"Nora","family":"de Bode","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emese","family":"Kroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon R.","family":"Sznitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janna","family":"Cousijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.cpr.2025.102581_bb0005","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1089\/can.2022.0091","article-title":"A double-blind, randomized, controlled crossover trial of Cannabis in adults with Tourette syndrome","volume":"8","author":"Abi-Jaoude","year":"2023","journal-title":"Cannabis and Cannabinoid Research"},{"issue":"3","key":"10.1016\/j.cpr.2025.102581_bb0010","doi-asserted-by":"crossref","first-page":"160","DOI":"10.35755\/jmedassocthai.2024.3.13952","article-title":"Efficacy and safety of Cannabidiol oil on chronic insomnia: The first randomized, double-blind, placebo-controlled, crossover, pilot study in Thailand","volume":"107","author":"Aiewtrakoon","year":"2024","journal-title":"Journal of the Medical Association of Thailand"},{"issue":"3","key":"10.1016\/j.cpr.2025.102581_bb0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jamapsychiatry.2013.3947","article-title":"Nabiximols as an agonist replacement therapy during cannabis withdrawal: A randomized clinical trial","volume":"71","author":"Allsop","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.cpr.2025.102581_bb0020","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013"},{"issue":"1","key":"10.1016\/j.cpr.2025.102581_bb0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/eat.22173","article-title":"Dronabinol in severe, enduring anorexia nervosa: A randomized controlled trial","volume":"47","author":"Andries","year":"2014","journal-title":"The International Journal of Eating Disorders"},{"issue":"3","key":"10.1016\/j.cpr.2025.102581_bb0030","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s10803-018-3808-2","article-title":"Brief report: Cannabidiol-rich Cannabis in children with autism Spectrum disorder and severe behavioral problems-A retrospective feasibility study","volume":"49","author":"Aran","year":"2019","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"4","key":"10.1016\/j.cpr.2025.102581_bb0035","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/YCO.0000000000000868","article-title":"Effects of cannabis legalization on the use of cannabis and other substances","volume":"36","author":"Assanangkornchai","year":"2023","journal-title":"Current Opinion in Psychiatry"},{"issue":"1","key":"10.1016\/j.cpr.2025.102581_bb0040","doi-asserted-by":"crossref","DOI":"10.1186\/s42238-022-00135-y","article-title":"A description of self-medication with cannabis among adults with legal access to cannabis in Quebec, Canada","volume":"4","author":"Asselin","year":"2022","journal-title":"Journal of Cannabis Research"},{"issue":"3","key":"10.1016\/j.cpr.2025.102581_bb0045","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.amepre.2022.09.019","article-title":"Effects of Cannabis legalization on adolescent Cannabis use across 3 studies","volume":"64","author":"Bailey","year":"2023","journal-title":"American Journal of Preventive Medicine"},{"issue":"6","key":"10.1016\/j.cpr.2025.102581_bb0050","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-na\u00efve social phobia patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"key":"10.1016\/j.cpr.2025.102581_bb0055","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.drugalcdep.2015.05.013","article-title":"The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone","volume":"154","author":"Bisaga","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"12","key":"10.1016\/j.cpr.2025.102581_bb0060","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S2215-0366(19)30401-8","article-title":"Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: A systematic review and meta-analysis","volume":"6","author":"Black","year":"2019","journal-title":"The Lancet. Psychiatry"},{"issue":"7","key":"10.1016\/j.cpr.2025.102581_bb0065","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s00213-018-4885-9","article-title":"The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial","volume":"235","author":"Boggs","year":"2018","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.cpr.2025.102581_bb0070","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s00213-021-06043-y","article-title":"Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder","volume":"239","author":"Bolsoni","year":"2022","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.cpr.2025.102581_bb0075","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1590\/1516-4446-2021-2317","article-title":"The anxiolytic effect of cannabidiol depends on the nature of the trauma when patients with post-traumatic stress disorder recall their trigger event","volume":"44","author":"Bolsoni","year":"2022","journal-title":"Revista Brasileira de Psiquiatria (Sao Paulo, Brazil: 1999)"},{"issue":"2","key":"10.1016\/j.cpr.2025.102581_bb0080","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1089\/can.2020.0056","article-title":"The long-term, prospective, therapeutic impact of Cannabis on post-traumatic stress disorder","volume":"7","author":"Bonn-Miller","year":"2022","journal-title":"Cannabis and Cannabinoid Research"},{"issue":"3","key":"10.1016\/j.cpr.2025.102581_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246990","article-title":"The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: A randomized cross-over clinical trial","volume":"16","author":"Bonn-Miller","year":"2021","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.cpr.2025.102581_bb0090","doi-asserted-by":"crossref","first-page":"592","DOI":"10.5694\/mja2.52313","article-title":"Is the current commercial model of medicinal cannabis in the best interest of patients?","volume":"220","author":"Bradlow","year":"2024","journal-title":"Medical Journal of Australia"},{"key":"10.1016\/j.cpr.2025.102581_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euroneuro.2020.02.003","article-title":"The blind men and the elephant: Systematic review of systematic reviews of cannabis use related health harms","volume":"33","author":"Campeny","year":"2020","journal-title":"European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.cpr.2025.102581_bb0100","doi-asserted-by":"crossref","DOI":"10.1042\/NS20220034","article-title":"Endocannabinoid signaling and epigenetics modifications in the neurobiology of stress-related disorders","volume":"7","author":"Coelho","year":"2023","journal-title":"Neuronal Signaling"},{"issue":"7","key":"10.1016\/j.cpr.2025.102581_bb0105","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/add.15743","article-title":"Clinical management of cannabis withdrawal","volume":"117","author":"Connor","year":"2022","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.cpr.2025.102581_bb0110","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.euroneuro.2017.05.005","article-title":"Cannabinoids in attention-deficit\/hyperactivity disorder: A randomised-controlled trial","volume":"27","author":"Cooper","year":"2017","journal-title":"European Neuropsychopharmacology"},{"issue":"58","key":"10.1016\/j.cpr.2025.102581_bb0115","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/jncimonographs\/lgab009","article-title":"Challenges for clinical Cannabis and cannabinoid research in the United States","volume":"2021","author":"Cooper","year":"2021","journal-title":"Journal of the National Cancer Institute. Monographs"},{"issue":"6","key":"10.1016\/j.cpr.2025.102581_bb0120","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.biopsych.2004.12.006","article-title":"Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction","volume":"57","author":"D\u2019Souza","year":"2005","journal-title":"Biological Psychiatry"},{"issue":"8","key":"10.1016\/j.cpr.2025.102581_bb0125","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","article-title":"The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis","volume":"29","author":"D\u2019Souza","year":"2004","journal-title":"Neuropsychopharmacology\u00a0: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.cpr.2025.102581_bb0130","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41386-022-01478-z","article-title":"Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios","volume":"48","author":"Englund","year":"2023","journal-title":"Neuropsychopharmacology\u00a0: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"S1","key":"10.1016\/j.cpr.2025.102581_bb0135","doi-asserted-by":"crossref","first-page":"377S","DOI":"10.1002\/j.1552-4604.1981.tb02617.x","article-title":"The efficacy and safety of nabilone (a synthetic cannabinoid) in the treatment of anxiety","volume":"21","author":"Fabre","year":"1981","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.cpr.2025.102581_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2024.108122","article-title":"Conceptualizing problematic use of medicinal Cannabis: Development and preliminary validation of a brief screening questionnaire","volume":"158","author":"Feingold","year":"2024","journal-title":"Addictive Behaviors"},{"issue":"10","key":"10.1016\/j.cpr.2025.102581_bb0145","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S2215-0366(20)30290-X","article-title":"Cannabidiol for the treatment of cannabis use disorder: A phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial","volume":"7","author":"Freeman","year":"2020","journal-title":"The Lancet. Psychiatry"},{"issue":"1","key":"10.1016\/j.cpr.2025.102581_bb0150","doi-asserted-by":"crossref","DOI":"10.1186\/s42238-024-00220-4","article-title":"Evaluation of dispensaries\u2019 cannabis flowers for accuracy of labeling of cannabinoids content","volume":"6","author":"Geweda","year":"2024","journal-title":"Journal of Cannabis Research"},{"issue":"3","key":"10.1016\/j.cpr.2025.102581_bb0155","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.2106","article-title":"Effect of medical marijuana card ownership on pain, insomnia, and affective disorder symptoms in adults: A randomized clinical trial","volume":"5","author":"Gilman","year":"2022","journal-title":"JAMA Network Open"},{"issue":"1","key":"10.1016\/j.cpr.2025.102581_bb0160","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/YIC.0000000000000382","article-title":"Tetrahydrocannabinol fails to reduce hair pulling or skin picking: Results of a double-blind, placebo-controlled study of dronabinol","volume":"37","author":"Grant","year":"2022","journal-title":"International Clinical Psychopharmacology"},{"issue":"3","key":"10.1016\/j.cpr.2025.102581_bb0165","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00004714-198306000-00004","article-title":"A double-blind trial of delta 9-tetrahydrocannabinol in primary anorexia nervosa","volume":"3","author":"Gross","year":"1983","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"3","key":"10.1016\/j.cpr.2025.102581_bb0170","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/17523281.2012.659751","article-title":"Marijuana impacts mood in bipolar disorder: A pilot study","volume":"5","author":"Gruber","year":"2012","journal-title":"Mental Health and Substance Use: Dual Diagnosis"},{"key":"10.1016\/j.cpr.2025.102581_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2024.104073","article-title":"Evaluation of the efficacy, safety, and pharmacokinetics of nanodispersible cannabidiol oral solution (150 mg\/mL) versus placebo in mild to moderate anxiety subjects: A double blind multicenter randomized clinical trial","volume":"97","author":"Gundugurti","year":"2024","journal-title":"Asian Journal of Psychiatry"},{"issue":"2","key":"10.1016\/j.cpr.2025.102581_bb0180","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/wps.20735","article-title":"Assessing the public health impacts of legalizing recreational cannabis use: The US experience","volume":"19","author":"Hall","year":"2020","journal-title":"World Psychiatry"},{"issue":"2","key":"10.1016\/j.cpr.2025.102581_bb0185","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1176\/appi.ajp.2021.21030320","article-title":"Risks and benefits of Cannabis and cannabinoids in psychiatry","volume":"179","author":"Hill","year":"2022","journal-title":"The American Journal of Psychiatry"},{"issue":"8","key":"10.1016\/j.cpr.2025.102581_bb0190","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/ajad.12622","article-title":"Nabilone pharmacotherapy for cannabis dependence: A randomized, controlled pilot study","volume":"26","author":"Hill","year":"2017","journal-title":"The American Journal on Addictions"},{"issue":"10","key":"10.1016\/j.cpr.2025.102581_bb0195","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/jamapsychiatry.2020.1035","article-title":"Association of high-potency cannabis use with mental health and substance use in adolescence","volume":"77","author":"Hines","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.cpr.2025.102581_bb0200","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00406-019-00984-4","article-title":"How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review","volume":"269","author":"Hoch","year":"2019","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"issue":"10202","key":"10.1016\/j.cpr.2025.102581_bb0205","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","article-title":"Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: A systematic review and network meta-analysis","volume":"394","author":"Huhn","year":"2019","journal-title":"Lancet (London, England)"},{"issue":"11","key":"10.1016\/j.cpr.2025.102581_bb0210","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1176\/appi.ajp.2019.18101191","article-title":"Cannabidiol for the reduction of Cue-induced craving and anxiety in drug-abstinent individuals with heroin use disorder: A double-blind randomized placebo-controlled trial","volume":"176","author":"Hurd","year":"2019","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.cpr.2025.102581_bb0215","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.psyneuen.2014.11.002","article-title":"The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study","volume":"51","author":"Jetly","year":"2015","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.cpr.2025.102581_bb0220","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1186\/s12889-023-15883-6","article-title":"Trends of cannabis use and related harms before and after legalization for recreational purpose in a developing country in Asia","volume":"23","author":"Kalayasiri","year":"2023","journal-title":"BMC Public Health"},{"issue":"8","key":"10.1016\/j.cpr.2025.102581_bb0225","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/da.23032","article-title":"Acute effects of cannabinoids on symptoms of obsessive-compulsive disorder: A human laboratory study","volume":"37","author":"Kayser","year":"2020","journal-title":"Depression and Anxiety"},{"key":"10.1016\/j.cpr.2025.102581_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.736822","article-title":"Cannabidiol cigarettes as adjunctive treatment for psychotic disorders \u2013 A randomized, Open-Label Pilot-Study","volume":"12","author":"K\u00f6ck","year":"2021","journal-title":"Frontiers in Psychiatry"},{"issue":"3","key":"10.1016\/j.cpr.2025.102581_bb0235","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/add.14776","article-title":"Heavy cannabis use, dependence and the brain: A clinical perspective","volume":"115","author":"Kroon","year":"2020","journal-title":"Addiction (Abingdon, England)"},{"key":"10.1016\/j.cpr.2025.102581_bb0240","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.euroneuro.2022.04.003","article-title":"Cannabidiol enhancement of exposure therapy in treatment refractory patients with social anxiety disorder and panic disorder with agoraphobia: A randomised controlled trial","volume":"59","author":"Kwee","year":"2022","journal-title":"European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.cpr.2025.102581_bb0245","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s00213-021-06047-8","article-title":"Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada","volume":"239","author":"Leung","year":"2022","journal-title":"Psychopharmacology"},{"issue":"1\u20133","key":"10.1016\/j.cpr.2025.102581_bb0250","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.drugalcdep.2010.12.010","article-title":"Dronabinol for the treatment of cannabis dependence: A randomized, double-blind, placebo-controlled trial","volume":"116","author":"Levin","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.cpr.2025.102581_bb0255","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Translational Psychiatry"},{"issue":"9","key":"10.1016\/j.cpr.2025.102581_bb0260","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/jamainternmed.2019.1993","article-title":"Nabiximols for the treatment of Cannabis dependence: A randomized clinical trial","volume":"179","author":"Lintzeris","year":"2019","journal-title":"JAMA Internal Medicine"},{"key":"10.1016\/j.cpr.2025.102581_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108220","article-title":"Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trial","volume":"215","author":"Lintzeris","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.cpr.2025.102581_bb0270","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12954-020-00377-0","article-title":"Medical cannabis use in the Australian community following introduction of legal access: The 2018-2019 online cross-sectional Cannabis as medicine survey (CAMS-18)","volume":"17","author":"Lintzeris","year":"2020","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.cpr.2025.102581_bb0275","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.drugalcdep.2016.05.002","article-title":"Opioid withdrawal suppression efficacy of oral dronabinol in opioid dependent humans","volume":"164","author":"Lofwall","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.cpr.2025.102581_bb0280","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12954-019-0278-6","article-title":"Medical cannabis patterns of use and substitution for opioids & other pharmaceutical drugs, alcohol, tobacco, and illicit substances; results from a cross-sectional survey of authorized patients","volume":"16","author":"Lucas","year":"2019","journal-title":"Harm Reduction Journal"},{"issue":"2","key":"10.1016\/j.cpr.2025.102581_bb0285","doi-asserted-by":"crossref","DOI":"10.1192\/bjo.2024.13","article-title":"Medicinal cannabis for treating post-traumatic stress disorder and comorbid depression: Real-world evidence","volume":"10","author":"Lynskey","year":"2024","journal-title":"BJPsych Open"},{"issue":"6","key":"10.1016\/j.cpr.2025.102581_bb0290","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s40266-024-01123-y","article-title":"Prescribed medical Cannabis use among older individuals: Patient characteristics and improvements in well-being: Findings from T21","volume":"41","author":"Lynskey","year":"2024","journal-title":"Drugs & Aging"},{"issue":"1","key":"10.1016\/j.cpr.2025.102581_bb0295","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s42238-020-00038-w","article-title":"Medical cannabis use in the United States: A retrospective database study","volume":"2","author":"Mahabir","year":"2020","journal-title":"Journal of Cannabis Research"},{"key":"10.1016\/j.cpr.2025.102581_bb0300","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.3389\/fpsyg.2019.02466","article-title":"Anxiolytic effects of repeated Cannabidiol treatment in teenagers with social anxiety disorders","volume":"10","author":"Masataka","year":"2019","journal-title":"Frontiers in Psychology"},{"issue":"4","key":"10.1016\/j.cpr.2025.102581_bb0305","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1360-0443.2000.9544912.x","article-title":"A longitudinal study of cannabis use and mental health from adolescence to early adulthood","volume":"95","author":"McGee","year":"2000","journal-title":"Addiction (Abingdon, England)"},{"issue":"3","key":"10.1016\/j.cpr.2025.102581_bb0310","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1176\/appi.ajp.2017.17030325","article-title":"Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: A multicenter randomized controlled trial","volume":"175","author":"McGuire","year":"2018","journal-title":"The American Journal of Psychiatry"},{"issue":"5","key":"10.1016\/j.cpr.2025.102581_bb0315","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1590\/1516-4446-2020-1416","article-title":"Cannabidiol for the treatment of crack-cocaine craving: An exploratory double-blind study","volume":"43","author":"Meneses-Gaya","year":"2021","journal-title":"Brazilian Journal of Psychiatry"},{"issue":"1","key":"10.1016\/j.cpr.2025.102581_bb0320","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12954-024-00992-1","article-title":"Medical cannabis use in Australia seven years after legalisation: Findings from the online Cannabis as medicine survey 2022\u20132023 (CAMS-22)","volume":"21","author":"Mills","year":"2024","journal-title":"Harm Reduction Journal"},{"issue":"9","key":"10.1016\/j.cpr.2025.102581_bb0325","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1111\/add.15417","article-title":"Cannabidiol as a treatment for craving and relapse in individuals with cocaine use disorder: A randomized placebo-controlled trial","volume":"116","author":"Mongeau-P\u00e9russe","year":"2021","journal-title":"Addiction (Abingdon, England)"},{"issue":"1","key":"10.1016\/j.cpr.2025.102581_bb0330","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/npp.2015.166","article-title":"Neurobiological interactions between stress and the endocannabinoid system","volume":"41","author":"Morena","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.cpr.2025.102581_bb0335","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.addbeh.2013.03.011","article-title":"Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings","volume":"38","author":"Morgan","year":"2013","journal-title":"Addictive Behaviors"},{"issue":"9","key":"10.1016\/j.cpr.2025.102581_bb0340","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300012","article-title":"Tetrahydrocannabinol and Cannabidiol in Tourette syndrome","volume":"2","author":"Mosley","year":"2023","journal-title":"NEJM Evidence"},{"issue":"1","key":"10.1016\/j.cpr.2025.102581_bb0345","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1055\/s-2001-15191","article-title":"Influence of treatment of Tourette syndrome with delta9-tetrahydrocannabinol (delta9-THC) on neuropsychological performance","volume":"34","author":"M\u00fcller-Vahl","year":"2001","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.cpr.2025.102581_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115135","article-title":"CANNA-TICS: Efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders\u2014Results of a prospective, multicenter, randomized, double-blind, placebo controlled, phase IIIb superiority study","volume":"323","author":"M\u00fcller-Vahl","year":"2023","journal-title":"Psychiatry Research"},{"issue":"2","key":"10.1016\/j.cpr.2025.102581_bb0355","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-2002-25028","article-title":"Treatment of Tourette\u2019s syndrome with Delta 9-tetrahydrocannabinol (THC): A randomized crossover trial","volume":"35","author":"M\u00fcller-Vahl","year":"2002","journal-title":"Pharmacopsychiatry"},{"issue":"4","key":"10.1016\/j.cpr.2025.102581_bb0360","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4088\/JCP.v64n0417","article-title":"Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: A 6-week randomized trial","volume":"64","author":"M\u00fcller-Vahl","year":"2003","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1016\/j.cpr.2025.102581_bb0365","doi-asserted-by":"crossref","first-page":"212","DOI":"10.18773\/austprescr.2015.072","article-title":"Medicinal cannabis","volume":"38","author":"Murnion","year":"2015","journal-title":"Australian Prescriber"},{"issue":"5","key":"10.1016\/j.cpr.2025.102581_bb0370","doi-asserted-by":"crossref","first-page":"753","DOI":"10.5664\/jcsm.10998","article-title":"Cannabidiol for moderate\u2013severe insomnia: A randomized controlled pilot trial of 150 mg of nightly dosing","volume":"20","author":"Narayan","year":"2024","journal-title":"Journal of Clinical Sleep Medicine"},{"key":"10.1016\/j.cpr.2025.102581_bb0375","series-title":"The health effects of Cannabis and cannabinoids: The current state of evidence and recommendations for research","author":"National Academies of Sciences, Engineering, and Medicine","year":"2017"},{"key":"10.1016\/j.cpr.2025.102581_bb0380","series-title":"Nationale drug monitor editie 2024 (Cannabis 3.2.4 Medicinaal Gebruik - Nationale drug monitor.)","author":"Nationale Drug Monitor","year":"2024"},{"key":"10.1016\/j.cpr.2025.102581_bb0385","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3389\/fpsyt.2020.00315","article-title":"Endocannabinoid system components as potential biomarkers in psychiatry","volume":"11","author":"Navarrete","year":"2020","journal-title":"Frontiers in Psychiatry"},{"issue":"11","key":"10.1016\/j.cpr.2025.102581_bb0390","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1111\/bcp.13687","article-title":"The challenges of \u201cmedical cannabis\u201d and mental health: A clinical perspective","volume":"84","author":"Newton-Howes","year":"2018","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.cpr.2025.102581_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2024.107981","article-title":"Cannabis advertising impacts on youth cannabis use intentions following recreational legalization in Canada: An ecological momentary assessment (EMA) study","volume":"153","author":"No\u00ebl","year":"2024","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.cpr.2025.102581_bb0400","article-title":"Why medical cannabis is still out of patients\u2019 reach-an essay by David Nutt","volume":"365","author":"Nutt","year":"2019","journal-title":"BMJ (Online)"},{"key":"10.1016\/j.cpr.2025.102581_bb0405","series-title":"THC-concentraties in wiet, nederwiet en hasj in Nederlandse coffeeshops 2022\u20142023 (drugs Informatie En monitoring Systeem (DIMS) Programma drug monitoring & policy)","author":"Oomen","year":"2024"},{"key":"10.1016\/j.cpr.2025.102581_bb0410","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"4","key":"10.1016\/j.cpr.2025.102581_bb0415","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/07067437231209650","article-title":"Cannabidiol as an Adjunctive Treatment for Acute Bipolar Depression: A Pilot Study: Le cannabidiol comme traitement d\u2019appoint de la d\u00e9pression bipolaire aigu\u00eb\u00a0: une \u00e9tude pilote","volume":"69","author":"Pinto","year":"2024","journal-title":"The Canadian Journal of Psychiatry"},{"issue":"3","key":"10.1016\/j.cpr.2025.102581_bb0420","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s40429-023-00500-8","article-title":"Transcultural aspects of Cannabis use: A descriptive overview of Cannabis use across cultures","volume":"10","author":"Rafei","year":"2023","journal-title":"Current Addiction Reports"},{"key":"10.1016\/j.cpr.2025.102581_bb0425","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.drugpo.2019.09.001","article-title":"Medical marijuana. What can we learn from the experiences in Canada, Germany and Thailand?","volume":"74","author":"Rehm","year":"2019","journal-title":"The International Journal on Drug Policy"},{"issue":"3","key":"10.1016\/j.cpr.2025.102581_bb0430","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.amepre.2023.03.005","article-title":"Increasing use of cannabis for medical purposes among U.S. residents, 2013-2020","volume":"65","author":"Rhee","year":"2023","journal-title":"American Journal of Preventive Medicine"},{"issue":"6","key":"10.1016\/j.cpr.2025.102581_bb0435","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3923\/ijp.2010.796.807","article-title":"Cannabis use and mental health: A review of recent epidemiological research","volume":"6","author":"Richardson","year":"2010","journal-title":"International Journal of Pharmacology"},{"issue":"3","key":"10.1016\/j.cpr.2025.102581_bb0440","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.13793","article-title":"Medicinal cannabis improves sleep in adults with insomnia: A randomised double-blind placebo-controlled crossover study","volume":"32","author":"Ried","year":"2023","journal-title":"Journal of Sleep Research"},{"issue":"1","key":"10.1016\/j.cpr.2025.102581_bb0445","first-page":"53","article-title":"Medical Cannabis use among adults in the southeastern United States","volume":"2","author":"Salazar","year":"2019","journal-title":"Cannabis (Albuquerque, N.M.)"},{"issue":"1","key":"10.1016\/j.cpr.2025.102581_bb0450","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12888-019-2409-8","article-title":"Medicinal cannabis for psychiatric disorders: A clinically-focused systematic review","volume":"20","author":"Sarris","year":"2020","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.cpr.2025.102581_bb0455","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.1027159","article-title":"The value of real world evidence: The case of medical cannabis","volume":"13","author":"Schlag","year":"2022","journal-title":"Frontiers in Psychiatry"},{"issue":"1","key":"10.1016\/j.cpr.2025.102581_bb0460","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/can.2016.0007","article-title":"A cross-sectional survey of medical Cannabis users: Patterns of use and perceived efficacy","volume":"1","author":"Sexton","year":"2016","journal-title":"Cannabis and Cannabinoid Research"},{"issue":"3","key":"10.1016\/j.cpr.2025.102581_bb0465","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1089\/acm.2018.0319","article-title":"A survey of Cannabis acute effects and withdrawal symptoms: Differential responses across user types and age","volume":"25","author":"Sexton","year":"2019","journal-title":"Journal of Alternative and Complementary Medicine (New York, N.Y.)"},{"issue":"3","key":"10.1016\/j.cpr.2025.102581_bb0470","doi-asserted-by":"crossref","first-page":"881","DOI":"10.4103\/jfmpc.jfmpc_824_23","article-title":"Global epidemiology of cannabis use disorders and its trend from 1990 to 2019: Benchmarking analysis of the global burden of disease study","volume":"13","author":"Shah","year":"2024","journal-title":"Journal of Family Medicine and Primary Care"},{"key":"10.1016\/j.cpr.2025.102581_bb0475","doi-asserted-by":"crossref","DOI":"10.47626\/2237-6089-2021-0396","article-title":"Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: Randomized, double-blind, and placebo-controlled clinical trial","author":"Silva Junior","year":"2024","journal-title":"Trends in Psychiatry and Psychotherapy"},{"key":"10.1016\/j.cpr.2025.102581_bb0480","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-072348","article-title":"Balancing risks and benefits of cannabis use: Umbrella review of meta-analyses of randomised controlled trials and observational studies","author":"Solmi","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.cpr.2025.102581_bb0485","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"6","key":"10.1016\/j.cpr.2025.102581_bb0490","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/dar.13116","article-title":"Trends in medical cannabis licensure, Israel, 2013-2018","volume":"39","author":"Sznitman","year":"2020","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.cpr.2025.102581_bb0495","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.addbeh.2017.09.026","article-title":"Rethinking indicators of problematic cannabis use in the era of medical cannabis legalization","volume":"77","author":"Sznitman","year":"2018","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.cpr.2025.102581_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109760","article-title":"Cannabis use and sleep quality in daily life: An electronic daily diary study of adults starting cannabis for health concerns","volume":"243","author":"Tervo-Clemmens","year":"2023","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.cpr.2025.102581_bb0505","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190768","article-title":"Nabiximols combined with motivational enhancement\/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial","volume":"13","author":"Trigo","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.cpr.2025.102581_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.comppsych.2020.152188","article-title":"Overlapping patterns of recreational and medical cannabis use in a large community sample of cannabis users","volume":"102","author":"Turna","year":"2020","journal-title":"Comprehensive Psychiatry"},{"issue":"1","key":"10.1016\/j.cpr.2025.102581_bb0515","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41398-022-02215-2","article-title":"The genetic aetiology of cannabis use: From twin models to genome-wide association studies and beyond","volume":"12","author":"Verweij","year":"2022","journal-title":"Translational Psychiatry"},{"key":"10.1016\/j.cpr.2025.102581_bb0520","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1146\/annurev-pharmtox-010716-104615","article-title":"Don\u2019t worry, be happy: Endocannabinoids and Cannabis at the intersection of stress and reward","volume":"57","author":"Volkow","year":"2017","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"3","key":"10.1016\/j.cpr.2025.102581_bb0525","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.3390\/ijerph19031850","article-title":"Predicting self-medication with Cannabis in young adults with hazardous Cannabis use","volume":"19","author":"Wallis","year":"2022","journal-title":"International Journal of Environmental Research and Public Health"},{"issue":"11","key":"10.1016\/j.cpr.2025.102581_bb0530","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsab149","article-title":"Treating insomnia symptoms with medicinal cannabis: A randomized, crossover trial of the efficacy of a cannabinoid medicine compared with placebo","volume":"44","author":"Walsh","year":"2021","journal-title":"Sleep"},{"key":"10.1016\/j.cpr.2025.102581_bb0535","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cpr.2016.10.002","article-title":"Medical cannabis and mental health: A guided systematic review","volume":"51","author":"Walsh","year":"2017","journal-title":"Clinical Psychology Review"},{"issue":"3","key":"10.1016\/j.cpr.2025.102581_bb0540","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1742-1241.2004.00271.x","article-title":"The medicinal use of cannabis in the UK: Results of a nationwide survey","volume":"59","author":"Ware","year":"2005","journal-title":"International Journal of Clinical Practice"},{"key":"10.1016\/j.cpr.2025.102581_bb0545","author":"Wells"},{"issue":"2","key":"10.1016\/j.cpr.2025.102581_bb0550","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jadohealth.2019.08.024","article-title":"Exposure to Cannabis Marketing in Social and Traditional Media and past-year use among adolescents in states with legal retail Cannabis","volume":"66","author":"Whitehill","year":"2020","journal-title":"Journal of Adolescent Health"},{"issue":"24","key":"10.1016\/j.cpr.2025.102581_bb0555","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for Medical Use: A Systematic Review and Meta-analysis","volume":"313","author":"Whiting","year":"2015","journal-title":"JAMA"},{"issue":"S1","key":"10.1016\/j.cpr.2025.102581_bb0560","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1192\/j.eurpsy.2023.306","article-title":"Medical cannabis use among patients with post-traumatic stress disorder (PTSD): A nationwide database study","volume":"66","author":"Yakirevich Amir","year":"2023","journal-title":"European Psychiatry"},{"issue":"1","key":"10.1016\/j.cpr.2025.102581_bb0565","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12888-019-2324-z","article-title":"Characterization of mental health in cannabis dispensary users, using structured clinical interviews and standardized assessment instruments","volume":"19","author":"Yau","year":"2019","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.cpr.2025.102581_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.pmedr.2021.101351","article-title":"Trends in youth cannabis use across cannabis legalization: Data from the COMPASS prospective cohort study","volume":"22","author":"Zuckermann","year":"2021","journal-title":"Preventive Medicine Reports"}],"container-title":["Clinical Psychology Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272735825000479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272735825000479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T02:05:22Z","timestamp":1747965922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272735825000479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":114,"alternative-id":["S0272735825000479"],"URL":"https:\/\/doi.org\/10.1016\/j.cpr.2025.102581","relation":{},"ISSN":["0272-7358"],"issn-type":[{"value":"0272-7358","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The differential effects of medicinal cannabis on mental health: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Clinical Psychology Review","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpr.2025.102581","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102581"}}